Why the DroneShield (ASX:DRO), BrainChip (ASX:BRN) and Recce (ASX:RCE) share prices are rising today

The share prices of these 3 ASX growth shares have all jumped today off the back of recent announcements. All are innovators in their fields.

| More on:
Red paper plane zooming ahead of an army of white paper plane competition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today has been very strong for a range of ASX sectors after yesterday's market fall. We've seen the share prices of a number of innovative ASX growth companies rise today, including the 3 listed below.

DroneShield Ltd (ASX: DRO)

The Droneshield share price is up by 23.33% at time of writing.

The company provides non-ballistic detect and disrupt technology for defending against drones. It recently announced it had obtained funding from the US Department of Defence (DoD) for enhancements to its DroneShieldComplete Command-and-Control (C2) system. Previously, the company had made several announcements. First, relating to sales to 2 European nations, and second, to a successful deployment in a mid-sized European airport. This has also had an impact on the company's share price.

At the conclusion of the project to enhance the DroneShieldComplete C2, the company anticipates selling additional products to the US DoD. DroneShield CEO Oleg Vornik said the project underscored the company's leadership not only as a product/sensor manufacturer, but also as an integrator of fixed site and mobile counter unmanned aircraft systems.

Recce Pharmaceuticals Ltd (ASX: RCE)

Recce (pronounced Recky) is a medical research company developing a new range of synthetic antibiotics. Unlike current approaches, Recce's products kill bacteria instead of inhibiting growth, enabling multiple use without a reduction in potency. 

Today the company announced it has selected South Australia's CMAX Clinical Research as its independent trial facility. The laboratory will conduct a phase I clinical study of Recce's lead compound RECCE 327.

This is a controlled ascending dose study of 48 healthy adult subjects, resulting in an evaluation of the safety and tolerability of the product after intravenous use. In response to the news, the Recce share price has risen by 3.14% at the time of writing. 

Brainchip Holdings Ltd (ASX: BRN)

The BrainChip share price is up by 3.33% at the time of writing, and has risen by 73.33% over the past 5 days.

BrainChip is an artificial intelligence (AI) company that has recently completed construction of the wafer of its newest product, a neuromorphic chip designed to mimic the human brain and sensory system.

The company has announced 2 proof of concept partnerships.

First, with Magik Eye Inc to combine AI with the Magik Eye's 3D sensing. This partnership will be targeting gesture recognition in a wide array of gaming and consumer products. Second, the Brainchip share price jumped 54% after the company announced a partnership with VORAGO Technologies to support a phase 1 project for NASA.

Motley Fool contributor Daryl Mather owns shares of Recce Pharmaceuticals Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

These ASX 200 shares could rise 50% to 80%

Analysts have good things to say about these shares and are predicting big returns.

Read more »

Two men celebrate while another holds his head in his hands, after watching the race.
Share Gainers

Here are the top 10 ASX 200 shares today

Despite the RBA, investors were back to the races this Tuesday.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Are Graincorp and PLS shares buys, holds, or sells?

Morgans has given its verdict on these shares.

Read more »

young female doctor with digital tablet looking confused.
Healthcare Shares

Will Telix shares drop below $10?

Telix shares are trading in the red again today.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Mergers & Acquisitions

Qantas shares higher on Jetstar Japan sale

The Flying Kangaroo is saying sayonara to one of its brands.

Read more »

Man climbing ladder to percentage sign, symbolising higher interest rates.
Share Market News

ASX 200 investors flinch as RBA pulls the trigger on higher interest rates

ASX 200 investors and mortgage holders alike are now facing higher interest rates.

Read more »

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

These 3 ASX 200 shares have soared over 200% in a year!

And here's what to expect from the high-climbers in 2026.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Share Market News

These were the 10 most traded Australian shares last week

These shares were on investors’ radars during the final week of January.

Read more »